The report provides a detailed analysis essential for establishing a Fenoldopam production plant. It encompasses all critical aspects necessary for Fenoldopam production, including the cost of Fenoldopam production, Fenoldopam plant cost, Fenoldopam production costs, and the overall Fenoldopam production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Fenoldopam production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Fenoldopam is a medication primarily used in the treatment of severe hypertension, especially in emergency or hospital settings. It is administered intravenously to rapidly lower blood pressure and improve blood flow to vital organs. It is a vasodilator that works by relaxing the blood vessels, which helps lower blood pressure quickly and effectively. It is also sometimes used in the management of kidney function, particularly in patients undergoing surgery or those with kidney-related issues, as it can improve renal blood flow.
It is often used in research to better understand the role of dopamine in cardiovascular health and kidney function. Moreover, it also plays a role in the development of other vasodilators aimed at treating high blood pressure and improving organ function in critically ill patients.
The primary factor that drives the demand for Fenoldopam is its application as an important tool in controlling critical blood pressure levels during medical treatments, which fuels its market growth. Its application as a vasodilator in the treatment of severe hypertension and hypertensive crises significantly contributes to its demand in the medical and pharmaceutical industries. Moreover, its use in improving renal blood flow in patients undergoing surgery or with kidney-related issues further supports its demand in critical care and emergency medicine.
Its involvement in clinical research to study its potential benefits in other areas, such as heart failure and other cardiovascular conditions, also contributes to its demand in the pharmaceutical research industry. Improvements in drug formulation, supplier reliability, and the growing focus on improving patient outcomes in cardiovascular care and kidney management also significantly impact the procurement and availability of Fenoldopam globally. Industrial Fenoldopam procurement is also influenced by several factors, including the cost and availability of raw materials, regulatory compliance, and the efficiency of production processes.
Raw Material for Fenoldopam Production
According to the Fenoldopam production plant project report, the major raw materials for Fenoldopam production include 2-Chloro-3,4-dimethoxyphenethylamine, p-Methoxystyrene Oxide, Trifluoroacetic Acid, Concentrated Sulfuric Acid, and Boron Tribromide.
Production Process of Fenoldopam
The extensive Fenoldopam production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of Fenoldopam begins with the reaction of 2-chloro-3,4-dimethoxyphenethylamine with p-methoxystyrene oxide to form a hydroxyphenethylamine intermediate. Then, this intermediate is treated with trifluoroacetic acid and a small amount of concentrated sulfuric acid. Further, the obtained compound undergoes purification using a silica gel column with chloroform and methanol as eluents to obtain the desired benzazepine compound. Then, the trimethoxy product is reacted with boron tribromide in dry methylene chloride to introduce hydroxyl groups. Further, the resulting compound is converted into its hydrobromide salt. The base is regenerated by treating the hydrobromide with sodium carbonate solution, and various salts, including the methanesulfonate, are formed, with the methanesulfonate being the most water-soluble form. The final product, Fenoldopam, is purified and isolated in the desired crystalline form.
Fenoldopam is a selective dopamine D1 receptor agonist primarily used to treat hypertension, particularly in acute settings. It appears as a white to off-white crystalline powder with a slight characteristic odour. The molecular formula of the compound is C16H16ClNO3, and its molecular mass is 305.75 g/mol. It has a density of around 1.38 g/cm³. It is soluble in water and alcohol. Its solubility in water is around 4000 mg/L. Fenoldopam has a boiling point of approximately 522.6 degree Celsius. Its prolonged exposure may lead to side effects such as tachycardia or hypotension. Therefore, it should be handled by using protective clothing to avoid accidental exposure.